{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:26:21Z","timestamp":1778797581044,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001465","name":"American Thoracic Society","doi-asserted-by":"publisher","award":["PG014635-01"],"award-info":[{"award-number":["PG014635-01"]}],"id":[{"id":"10.13039\/100001465","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["PT24-4036"],"award-info":[{"award-number":["PT24-4036"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001312","name":"Charles H Revson Foundation Inc","doi-asserted-by":"publisher","award":["1467160"],"award-info":[{"award-number":["1467160"]}],"id":[{"id":"10.13039\/100001312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI124413"],"award-info":[{"award-number":["R01AI124413"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1L60A1194399"],"award-info":[{"award-number":["1L60A1194399"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["2T32HL105323-06A1"],"award-info":[{"award-number":["2T32HL105323-06A1"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI167795"],"award-info":[{"award-number":["R01AI167795"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003442","name":"Stony Wold Herbert Fund Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003442","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Epidemiology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.annepidem.2026.110082","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:07:46Z","timestamp":1774883266000},"page":"110082","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Early adherence predicts treatment outcomes and mortality in people living with HIV and multidrug-resistant tuberculosis"],"prefix":"10.1016","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0817-6891","authenticated-orcid":false,"given":"Kevin J.","family":"Guzman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rubeshan","family":"Perumal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Resha","family":"Boodhram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boitumelo","family":"Seepamore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Rivet Amico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying Kuen","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Friedland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Zelnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amrita","family":"Daftary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nesri","family":"Padayatchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kogieleum","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max R.","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.annepidem.2026.110082_bib1","doi-asserted-by":"crossref","first-page":"E559","DOI":"10.1016\/S1473-3099(24)00144-0","article-title":"The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis \u2013 lessons from the South African experience","volume":"24","author":"Naidoo","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.annepidem.2026.110082_bib2","unstructured":"Global Tuberculosis Report 2024, 1st ed (Geneva: World Health Organization, 2024) [accessed April 28th, 2025]. Available from: https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2024."},{"issue":"3","key":"10.1016\/j.annepidem.2026.110082_bib3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/QAI.0000000000002940","article-title":"Bedaquiline adherence measured by electronic dose monitoring predicts clinical outcomes in the treatment of patients with multidrug-resistant tuberculosis and HIV\/AIDS","volume":"90","author":"O\u2019Donnell","year":"2022","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"10.1016\/j.annepidem.2026.110082_bib4","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/cid\/ciac232","article-title":"Adherence measured using electronic dose monitoring is associated with emergent antiretroviral resistance and poor outcomes in people with human immunodeficiency virus\/AIDS and multidrug-resistant tuberculosis","volume":"75","author":"Bateman","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.annepidem.2026.110082_bib5","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1016\/S2352-3018(19)30035-9","article-title":"Antiretroviral switching and bedaquiline treatment of drug-resistant tuberculosis HIV co-infection","volume":"6","author":"O\u2019Donnell","year":"2019","journal-title":"Lancet HIV"},{"issue":"10","key":"10.1016\/j.annepidem.2026.110082_bib6","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.socscimed.2012.01.027","article-title":"HIV and tuberculosis: the construction and management of double stigma","volume":"74","author":"Daftary","year":"2012","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.annepidem.2026.110082_bib7","doi-asserted-by":"crossref","unstructured":"Mallick J.S., Nair P., Abbew E.T., Van Deun A., Decroo T. Acquired bedaquiline resistance during the treatment of drug-resistant tuberculosis: a systemic review. JAC Antimicrob Resist. 2002; 4 (2): dlac029.","DOI":"10.1093\/jacamr\/dlac029"},{"issue":"6","key":"10.1016\/j.annepidem.2026.110082_bib8","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02383-2019","article-title":"Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients","volume":"55","author":"Nimmo","year":"2020","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.annepidem.2026.110082_bib9","article-title":"Modelling the epidemiological and economic impact of digital adherence technologies with differentiated care for tuberculosis treatment in Ethiopia","volume":"9","author":"Gosc\u00e9","year":"2024","journal-title":"BMJ Glob Health"},{"issue":"7","key":"10.1016\/j.annepidem.2026.110082_bib10","first-page":"e1053","article-title":"Treatment adherence and clinical outcomes among people with drug-susceptible tuberculosis using a medication monitor and differentiated care approach compared with standard of care in South Africa: a cluster randomised trial","volume":"12","author":"Charalambous","year":"2024","journal-title":"Lancet Glob Health"},{"issue":"9","key":"10.1016\/j.annepidem.2026.110082_bib11","first-page":"1142","article-title":"Temporal factors and missed doses of tuberculosis treatment: a causal associations approach to analyses of digital adherence data","volume":"17","author":"Stagg","year":"2020","journal-title":"Ann Am Thorac Soc"},{"issue":"12","key":"10.1016\/j.annepidem.2026.110082_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002884","article-title":"The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials","volume":"16","author":"Vernon","year":"2019","journal-title":"PLoS Med"},{"issue":"5","key":"10.1016\/j.annepidem.2026.110082_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(23)00068-2","article-title":"Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trial","volume":"11","author":"Liu","year":"2023","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.annepidem.2026.110082_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-056685","article-title":"Application of data-driven XGBoost model for the prediction of COVID-19 in the USA: a time-series study","volume":"12","author":"Fang","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.annepidem.2026.110082_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.rinp.2021.104462","article-title":"Time series prediction of COVID-19 transmission in America using LSTM and XGBoost algorithms","volume":"27","author":"Luo","year":"2021","journal-title":"Results Phys"},{"issue":"3","key":"10.1016\/j.annepidem.2026.110082_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10654-020-00615-6","article-title":"Identifying typical trajectories in longitudinal data: modelling strategies and interpretations","volume":"35","author":"Herle","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.annepidem.2026.110082_bib17","doi-asserted-by":"crossref","first-page":"e479","DOI":"10.1016\/S2214-109X(20)30548-9","article-title":"Dynamic Needs and Challenges of People with Drug-Resistant Tuberculosis in South Africa: a Qualitative Study","volume":"9","author":"Daftary","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.annepidem.2026.110082_bib18","unstructured":"Definitions and reporting frameworks for tuberculosis \u2013 2013 revisions (updated December 2014 and January 2020). Geneva: World Health Organization. [Accessed May 4, 2025]. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/79199\/9789241505345_eng.pdf?sequence=1."},{"key":"10.1016\/j.annepidem.2026.110082_bib19","first-page":"785","article-title":"XGBoost: a scalable tree boosting system","author":"Chen","year":"2016","journal-title":"KDD Proc ACM SIGKDD Int Conf Knowl Discov Data Min"},{"issue":"8","key":"10.1016\/j.annepidem.2026.110082_bib20","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1109\/JBHI.2022.3171673","article-title":"Dynamic sepsis prediction for intensive care unit patients using XGBoost-based model with novel time-dependent features","volume":"26","author":"Liu","year":"2022","journal-title":"IEEE J Biomed Health Inf"},{"issue":"2","key":"10.1016\/j.annepidem.2026.110082_bib21","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.jeconom.2007.02.002","article-title":"Inverse probability weighted estimation for general missing data problems","volume":"141","author":"Wooldridge","year":"2007","journal-title":"J Econ"},{"issue":"1","key":"10.1016\/j.annepidem.2026.110082_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0318349","article-title":"On the estimation of inverse-probability-of-censoring weights for the evaluation of survival prediction error","volume":"20","author":"Prince","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.annepidem.2026.110082_bib23","doi-asserted-by":"crossref","DOI":"10.1164\/ajrccm.2025.211.Abstracts.A1036","article-title":"Socio-ecologic factors impacting medication adherence trajectories in patients with drug-resistant tuberculosis and human immunodeficiency virus","volume":"211","author":"Guzman","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.annepidem.2026.110082_bib24","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0031-3203(96)00142-2","article-title":"The use of the area under the ROC curve in the evaluation of machine learning algorithms","volume":"30","author":"Bradley","year":"1997","journal-title":"Pattern Recognit"},{"issue":"1","key":"10.1016\/j.annepidem.2026.110082_bib25","first-page":"168","article-title":"Classification assessment methods","volume":"17","author":"Tharwat","year":"2021","journal-title":"Appl Comput Inf"},{"issue":"4","key":"10.1016\/j.annepidem.2026.110082_bib26","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/10705510701575396","article-title":"Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo simulation study","volume":"14","author":"Nylund","year":"2007","journal-title":"Struct Equ Model"},{"key":"10.1016\/j.annepidem.2026.110082_bib27","first-page":"195","article-title":"An entropy criterion for assessing the number of clusters in a mixture model","volume":"13","author":"Cleux","year":"1996","journal-title":"J Cl"},{"issue":"4","key":"10.1016\/j.annepidem.2026.110082_bib28","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.csda.2004.11.004","article-title":"Evaluating latent class analysis models in qualitative phenotype identification","volume":"50","author":"Yang","year":"2006","journal-title":"Comput Stat Data Anal"},{"issue":"1","key":"10.1016\/j.annepidem.2026.110082_bib29","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1186\/s13063-023-07520-9","article-title":"Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa (ADAP-TIV): study protocol for an adaptive randomized controlled trial","volume":"24","author":"Ross","year":"2023","journal-title":"Trials"},{"key":"10.1016\/j.annepidem.2026.110082_bib30","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1186\/s12879-021-06833-x","article-title":"Evaluation of implementation and effectiveness of digital adherence technology with differentiated care to support tuberculosis treatment adherence and improve treatment outcomes in Ethiopia: a study protocol for a cluster randomized trial","volume":"21","author":"Tadesse","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"25","key":"10.1016\/j.annepidem.2026.110082_bib31","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1056\/NEJMoa2117166","article-title":"A 24-week, all-oral regimen for rifampin-resistant tuberculosis","volume":"387","author":"Nyang\u2019wa","year":"2022","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.annepidem.2026.110082_bib32","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1901814","article-title":"Bedaquiline\u2013pretomanid\u2013linezolid regimens for drug-resistant tuberculosis","volume":"382","author":"Conradie","year":"2020","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.annepidem.2026.110082_bib33","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa2119430","article-title":"Bedaquiline\u2013pretomanid\u2013linezolid regimens for drug-resistant tuberculosis","volume":"387","author":"Conradie","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annepidem.2026.110082_bib34","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJMoa2400327","article-title":"Oral regimen for rifampin-resistant fluroquinolone-susceptible tuberculosis","volume":"392","author":"Guglielmetti","year":"2025","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.annepidem.2026.110082_bib35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s40121-013-0009-3","article-title":"A review of the evidence for using bedaquiline (TMC207) to treat multi-drug resistant tuberculosis","volume":"2","author":"Fox","year":"2013","journal-title":"Infect Dis Ther"},{"issue":"11","key":"10.1016\/j.annepidem.2026.110082_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277078","article-title":"Adherence trajectory as an on-treatment risk indicator among drug-resistant tuberculosis patients in the Philippines","volume":"17","author":"Huddart","year":"2022","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.annepidem.2026.110082_bib37","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/pubmed\/fdae018","article-title":"Investigating socio-ecological factors influencing implementation of tuberculosis infection prevention and control in rural Papua New Guinea","volume":"46","author":"Marme","year":"2024","journal-title":"J Public Health"},{"key":"10.1016\/j.annepidem.2026.110082_bib38","article-title":"Using a medication event monitoring system to evaluate self-report and pill count for determining treatment completion with self-administered, once-weekly isoniazid and rifapentine","volume":"129","author":"Scott","year":"2023","journal-title":"Conte Clin Trials"},{"issue":"1","key":"10.1016\/j.annepidem.2026.110082_bib39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/ijcm.IJCM_813_21","article-title":"Prevalence and determinants of depression among multidrug-resistant (MDR) TB cases registered under national tuberculosis elimination program in Ahmedabad City","volume":"47","author":"Sharma","year":"2022","journal-title":"Indian J Community Med"}],"container-title":["Annals of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279726000803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279726000803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:53:13Z","timestamp":1778795593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047279726000803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":39,"alternative-id":["S1047279726000803"],"URL":"https:\/\/doi.org\/10.1016\/j.annepidem.2026.110082","relation":{},"ISSN":["1047-2797"],"issn-type":[{"value":"1047-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early adherence predicts treatment outcomes and mortality in people living with HIV and multidrug-resistant tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Annals of Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annepidem.2026.110082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110082"}}